Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

60 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement.
Mack U, Migliori GB, Sester M, Rieder HL, Ehlers S, Goletti D, Bossink A, Magdorf K, Hölscher C, Kampmann B, Arend SM, Detjen A, Bothamley G, Zellweger JP, Milburn H, Diel R, Ravn P, Cobelens F, Cardona PJ, Kan B, Solovic I, Duarte R, Cirillo DM; C. Lange; TBNET. Mack U, et al. Among authors: milburn h. Eur Respir J. 2009 May;33(5):956-73. doi: 10.1183/09031936.00120908. Eur Respir J. 2009. PMID: 19407047 Free article.
The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement.
Bumbacea D, Arend SM, Eyuboglu F, Fishman JA, Goletti D, Ison MG, Jones CE, Kampmann B, Kotton CN, Lange C, Ljungman P, Milburn H, Morris MI, Muller E, Muñoz P, Nellore A, Rieder HL, Sester U, Theodoropoulos N, Wagner D, Sester M. Bumbacea D, et al. Among authors: milburn h. Eur Respir J. 2012 Oct;40(4):990-1013. doi: 10.1183/09031936.00000712. Epub 2012 Apr 10. Eur Respir J. 2012. PMID: 22496318 Free article. Review.
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement.
Solovic I, Sester M, Gomez-Reino JJ, Rieder HL, Ehlers S, Milburn HJ, Kampmann B, Hellmich B, Groves R, Schreiber S, Wallis RS, Sotgiu G, Schölvinck EH, Goletti D, Zellweger JP, Diel R, Carmona L, Bartalesi F, Ravn P, Bossink A, Duarte R, Erkens C, Clark J, Migliori GB, Lange C. Solovic I, et al. Among authors: milburn hj. Eur Respir J. 2010 Nov;36(5):1185-206. doi: 10.1183/09031936.00028510. Epub 2010 Jun 7. Eur Respir J. 2010. PMID: 20530046 Free article.
Risk assessment of tuberculosis in immunocompromised patients. A TBNET study.
Sester M, van Leth F, Bruchfeld J, Bumbacea D, Cirillo DM, Dilektasli AG, Domínguez J, Duarte R, Ernst M, Eyuboglu FO, Gerogianni I, Girardi E, Goletti D, Janssens JP, Julander I, Lange B, Latorre I, Losi M, Markova R, Matteelli A, Milburn H, Ravn P, Scholman T, Soccal PM, Straub M, Wagner D, Wolf T, Yalcin A, Lange C; TBNET. Sester M, et al. Among authors: milburn h. Am J Respir Crit Care Med. 2014 Nov 15;190(10):1168-76. doi: 10.1164/rccm.201405-0967OC. Am J Respir Crit Care Med. 2014. PMID: 25303140 Clinical Trial.
Fluoroquinolones and isoniazid-resistant tuberculosis: implications for the 2018 WHO guidance.
Stagg HR, Bothamley GH, Davidson JA, Kunst H, Lalor MK, Lipman MC, Loutet MG, Lozewicz S, Mohiyuddin T, Abbara A, Alexander E, Booth H, Creer DD, Harris RJ, Kon OM, Loebinger MR, McHugh TD, Milburn HJ, Palchaudhuri P, Phillips PPJ, Schmok E, Taylor L, Abubakar I; London INH-R TB study group. Stagg HR, et al. Among authors: milburn hj. Eur Respir J. 2019 Oct 10;54(4):1900982. doi: 10.1183/13993003.00982-2019. Print 2019 Oct. Eur Respir J. 2019. PMID: 31371444 Free PMC article.
Management of multiple drug-resistant tuberculosis.
Hutchison DC, Drobniewski FA, Milburn HJ. Hutchison DC, et al. Among authors: milburn hj. Respir Med. 2003 Jan;97(1):65-70. doi: 10.1053/rmed.2002.1412. Respir Med. 2003. PMID: 12556013 Free article.
Point-of-care urine test for assessing adherence to isoniazid treatment for tuberculosis.
Soobratty MR, Whitfield R, Subramaniam K, Grove G, Carver A, O'Donovan GV, Wu HH, Lee OY, Swaminathan R, Cope GF, Milburn HJ. Soobratty MR, et al. Among authors: milburn hj. Eur Respir J. 2014 May;43(5):1519-22. doi: 10.1183/09031936.00132613. Epub 2014 Jan 16. Eur Respir J. 2014. PMID: 24435008 Free article. No abstract available.
Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study.
Abubakar I, Drobniewski F, Southern J, Sitch AJ, Jackson C, Lipman M, Deeks JJ, Griffiths C, Bothamley G, Lynn W, Burgess H, Mann B, Imran A, Sridhar S, Tsou CY, Nikolayevskyy V, Rees-Roberts M, Whitworth H, Kon OM, Haldar P, Kunst H, Anderson S, Hayward A, Watson JM, Milburn H, Lalvani A; PREDICT Study Team. Abubakar I, et al. Among authors: milburn h. Lancet Infect Dis. 2018 Oct;18(10):1077-1087. doi: 10.1016/S1473-3099(18)30355-4. Epub 2018 Aug 30. Lancet Infect Dis. 2018. PMID: 30174209 Free PMC article.
Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment.
Coussens AK, Wilkinson RJ, Hanifa Y, Nikolayevskyy V, Elkington PT, Islam K, Timms PM, Venton TR, Bothamley GH, Packe GE, Darmalingam M, Davidson RN, Milburn HJ, Baker LV, Barker RD, Mein CA, Bhaw-Rosun L, Nuamah R, Young DB, Drobniewski FA, Griffiths CJ, Martineau AR. Coussens AK, et al. Among authors: milburn hj. Proc Natl Acad Sci U S A. 2012 Sep 18;109(38):15449-54. doi: 10.1073/pnas.1200072109. Epub 2012 Sep 4. Proc Natl Acad Sci U S A. 2012. PMID: 22949664 Free PMC article. Clinical Trial.
60 results